- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review ; volume:15 ; number:1 ; day:28 ; month:7 ; year:2022 ; pages:1-18 ; date:12.2022
Journal of ovarian research ; 15, Heft 1 (28.7.2022), 1-18, 12.2022
- Creator
-
Nag, Shona
Aggarwal, Shyam
Rauthan, Amit
Warrier, Narayanankutty
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-022-01020-1
- URN
-
urn:nbn:de:101:1-2022102309311799553958
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nag, Shona
- Aggarwal, Shyam
- Rauthan, Amit
- Warrier, Narayanankutty
- SpringerLink (Online service)
Other Objects (12)
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Poly (adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitors as maintenance therapy in women with newly diagnosed ovarian cancer: a systematic review and meta-analysis
Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Poly (adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitors as maintenance therapy in women with newly diagnosed ovarian cancer: a systematic review and meta-analysis
Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase
Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
Sarcopenia diagnosed by computed tomography predicts postoperative complications in advanced epithelial ovarian cancer
Poly (adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitors as maintenance therapy in women with newly diagnosed ovarian cancer: a systematic review and meta-analysis
Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma